Publications & Research

    Representative publications and intellectual property relevant to Inolyt's core innovation.

    DNA-AgNC Core Technology

    iNANP Technologies

    Intellectual Property

    Functionally-interdependent shape-switching nucleic acid nanoparticles

    US 11,512,313

    RNA-DNA Fusomers with Tunable Physicochemical, Mechanical, and Biological Properties for Diverse Biomedical Applications

    US 19/189,926

    Nucleic Acid Nanoparticles for Tunable Antiviral-like Immunomodulatory Responses and Potent Adjuvant Activity

    US 63/879,193

    Pending

    Induction of an Efficient Antiviral State by Immunostimulatory Nucleic Acid Nanoparticles (iNANPs)

    63/906,116

    Pending

    Spatial Organization of Silver Nanoclusters for Antibacterial Treatments

    US 63/894,335

    Pending

    Immunostimulatory RNA rings with Antibacterial DNA-templated Silver Nanoclusters and Methods of Use Thereof

    Application in progress

    Pending

    AI-Guided Prediction of Nucleic Acid Nanoparticles Immune Recognitions

    US 63/902,772

    Pending